Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Sana Pharma Holding AS
AS
Active
Org 916070721
Philip Pedersens Vei 20, 1366
Lysaker
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2015 · 10 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Sana Pharma Holding AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
6M
5M
3M
2M
0M
2015: 0M
0M
2015
2016: 2M
2M
2016
2017: 5M (+150% vs 2016)
5M
+150%
2017
2018: 1M (-80% vs 2017)
1M
-80%
2018
2019: 1M (0% vs 2018)
1M
0%
2019
EBITDA
NOK millions
0M
-6M
-11M
-17M
-22M
2015: 0M
0M
2015
2016: -18M
-18M
2016
2017: -12M (+33% vs 2016)
-12M
+33%
2017
2018: -8M (+33% vs 2017)
-8M
+33%
2018
2019: -7M (+13% vs 2018)
-7M
+13%
2019
Income statement
NOK thousands
Item
2019
2018
2017
2016
2015
Revenue
635
885
4 864
1 701
0
Staff expenses
−5 151
−6 655
−12 649
−11 144
−0
EBITDA
−6 534
−8 088
−11 783
−17 708
−157
Depreciation & amort.
−476
−417
−215
−7
−0
EBIT
−7 010
−8 504
−11 998
−17 715
−157
Net financials
−37 874
−33 749
834 844
102 328
20 157
Profit before tax
−44 884
−42 254
822 846
84 613
20 000
Tax
−0
−0
−22
22
−0
Net profit
−44 884
−42 254
822 868
84 591
20 000
Balance sheet
NOK thousands
Item
2019
2018
2017
2016
2015
Total assets
631 576
687 756
857 160
327 133
20 651
Equity
624 522
685 405
847 659
104 791
20 200
Long-term debt
0
0
1 612
80 351
0
Short-term debt
7 054
2 350
7 889
141 990
451
Total debt
7 054
2 350
9 501
222 341
451
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2015
2019
Equity ratio
98,9 %
This company
38,2 %
Market median
This company
Market median
159% above market
2015
2019
Return on equity
−7,2 %
This company
18,4 %
Market median
This company
Market median
139% below market
2015
2019
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2015
2019
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2015
2019
Debt / equity
0,01×
This company
0,62×
Market median
This company
Market median
98% below market
2015
2019
Annual reports & filings
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
View
PDF
Annual report 2015
Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
View
PDF
More on Sana Pharma Holding AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
